MicroRNA based treatment targeting lcp-1 positive cancer

摘要

The present invention relates toMir-16-5 pMir-23a-5pMir-125b-5pMir-145-5pMir-144a-3pMir-181c-5pMir-22-5pMir-455-3pIncluding - 7b-5p,AndAnd further from oneor more miRNAs selected from the group measure of mir-30a-5pMir-30b-5p,Mir-30c-5pMir-30d-5pMir-30e-5pMir-194-5pMir-302a-3pMir-302a-5pMir-335-3pMir-35-5pMir-367 - 3PMir-373 - 3PA panel of miRNA that further contains one or more miRNAs selected from the group consisting of mir-885-5p and the panel of said miRNAFor example:Derived from stem cellsIt relates to extracellular vesicles (EV).The present invention further provides the panel or eV for use in a method of treating an lcp-1 positive cancer patient.